Knight Therapeutics Inc T.GUD

Increasing revenues through pandemic!

[GoldenInvestor]

Looking at the Knight investor fact sheet, august 2022,
as the team have grown Knight, incorporating GBT, revenues have increased over $10MM TO $75.8MM.

YTD rev increase almost up by $28MM

EBITDA also cruising by 2021 by more than 2*!

$31mm vs $15mm

GI

[MrMugsy]

Which is why it's really easy to grow overall revenue based on adding a single drug to ROW. Imagine what you could do with a couple drugs - OR - by adding a portfolio. Same thing if you can bring a branded generic (or a few branded generics) online. Lots of ways to grow - early days. Also can move into additional geographies ... but ... that's likely something for down the road.

[Chianchin]

BTW for anyone new in this forum Gold and Mugsy is the same person with different alias  pedling a lost cause GUD for ten years and nothing to show for other than huse loses as high as 90% one caluculating the opportunity loss and his/her avarage cost near $8